Volume 58, Issue 1, Pages (July 2000)

Slides:



Advertisements
Similar presentations
Volume 59, Issue 6, Pages (June 2001)
Advertisements

Volume 64, Issue 6, Pages (December 2003)
Volume 63, Issue 1, Pages (January 2003)
Volume 77, Issue 6, Pages (March 2010)
Volume 131, Issue 3, Pages (September 2006)
Volume 66, Issue 3, Pages (September 2004)
Renal denervation prevents long-term sequelae of ischemic renal injury
Volume 70, Issue 2, Pages (July 2006)
Volume 58, Issue 2, Pages (August 2000)
Volume 62, Issue 1, Pages (July 2002)
Volume 69, Issue 8, Pages (April 2006)
Volume 67, Issue 3, Pages (March 2005)
Volume 67, Issue 2, Pages (February 2005)
Volume 68, Issue 5, Pages (November 2005)
Volume 67, Issue 5, Pages (May 2005)
Volume 64, Issue 1, Pages (July 2003)
Volume 81, Issue 7, Pages (April 2012)
Functional evidence confirmed by histological localization: overlapping expression of erythropoietin and HIF-2α in interstitial fibroblasts of the renal.
Volume 58, Issue 6, Pages (December 2000)
Volume 62, Issue 1, Pages (July 2002)
Epidermal growth factor receptor inhibition attenuates early kidney enlargement in experimental diabetes  Lesley Wassef, Darren J. Kelly, Richard E. Gilbert 
Volume 66, Issue 5, Pages (November 2004)
Volume 55, Issue 6, Pages (June 1999)
Volume 57, Issue 6, Pages (June 2000)
Volume 54, Issue 3, Pages (September 1998)
Volume 57, Issue 3, Pages (March 2000)
Volume 68, Issue 3, Pages (September 2005)
Volume 54, Issue 1, Pages (July 1998)
Volume 80, Issue 10, Pages (November 2011)
Volume 59, Issue 4, Pages (April 2001)
Volume 59, Issue 5, Pages (May 2001)
Volume 59, Issue 4, Pages (April 2001)
Heterozygous disruption of activin receptor–like kinase 1 is associated with increased renal fibrosis in a mouse model of obstructive nephropathy  José.
Volume 56, Issue 3, Pages (September 1999)
Yang Wang, Yi Ping Wang, Yuet-Ching Tay, David C.H. Harris 
Volume 54, Issue 5, Pages (November 1998)
Hepatocyte growth factor suppresses interstitial fibrosis in a mouse model of obstructive nephropathy  Shinya Mizuno, Kunio Matsumoto, Toshikazu Nakamura 
Activation of Erk1/2 and Akt following unilateral ureteral obstruction
Volume 57, Issue 3, Pages (March 2000)
Volume 64, Issue 4, Pages (October 2003)
Volume 62, Issue 3, Pages (September 2002)
Volume 63, Issue 5, Pages (May 2003)
Volume 58, Issue 1, Pages (July 2000)
Calcium citrate ameliorates the progression of chronic renal injury
Volume 61, Issue 6, Pages (June 2002)
Tight blood pressure control decreases apoptosis during renal damage
Takashi Ehara, Hidekazu Shigematsu  Kidney International 
Volume 60, Issue 1, Pages (July 2001)
Volume 63, Issue 6, Pages (June 2003)
Volume 63, Issue 4, Pages (April 2003)
Volume 55, Issue 3, Pages (March 1999)
Volume 55, Issue 1, Pages (January 1999)
Volume 84, Issue 4, Pages (October 2013)
Volume 58, Issue 2, Pages (August 2000)
Volume 67, Issue 2, Pages (February 2005)
C5b-9 regulates peritubular myofibroblast accumulation in experimental focal segmental glomerulosclerosis  Gopala K. Rangan, Jeffrey W. Pippin, William.
Volume 82, Issue 2, Pages (July 2012)
M.-J. Wu, M.-C. Wen, Y.-T. Chiu, Y.-Y. Chiou, K.-H. Shu, M.-J. Tang 
Volume 63, Issue 3, Pages (March 2003)
CD4+ T cells: a potential player in renal fibrosis
James Gailit, Mary J. Marchese, Richard R. Kew, Barry L. Gruber 
Volume 60, Issue 5, Pages (November 2001)
Volume 54, Pages S36-S40 (December 1998)
Interferon-γ inhibits experimental renal fibrosis
Volume 65, Issue 5, Pages (May 2004)
Role of immunocompetent cells in nonimmune renal diseases
Volume 70, Issue 2, Pages (July 2006)
Volume 59, Issue 2, Pages (February 2001)
Volume 68, Issue 1, Pages (July 2005)
Volume 68, Issue 5, Pages (November 2005)
Presentation transcript:

Volume 58, Issue 1, Pages 51-61 (July 2000) Mycophenolate mofetil reduces myofibroblast infiltration and collagen III deposition in rat remnant kidney  Chérif Badid, Madeleine Vincent, Brigitte Mcgregor, Martine Melin, Aoumeur Hadj-Aissa, Cécile Veysseyre, Daniel J. Hartmann, Alexis Desmouliere, Maurice Laville  Kidney International  Volume 58, Issue 1, Pages 51-61 (July 2000) DOI: 10.1046/j.1523-1755.2000.00140.x Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 1 Proteinuria (A) and creatinine clearance normalized to remnant kidney weight (B) in mycophenolate mofetil (MMF) treated (○) and untreated (•) rats during the follow-up period. *P < 0.05 vs. untreated rats. Kidney International 2000 58, 51-61DOI: (10.1046/j.1523-1755.2000.00140.x) Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 2 Interstitial α-smooth muscle actin (α-SMA) immunostaining (A) and type III collagen deposition (B) in treated (□) and untreated (▪) rats during the follow-up period. Values are expressed as a percentage of the surface area labeled by the appropriate antibody. *P < 0.05; ***P < 0.005 vs. untreated rats. Kidney International 2000 58, 51-61DOI: (10.1046/j.1523-1755.2000.00140.x) Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 3 Representative interstitial immunostaining for α-SMA antibody in untreated (on the left) and treated (on the right) rats, at week 2 (A and C) and at week 12 (B and D) after subtotal nephrectomy (×250). Reproduction of this figure in color was made possible by Ezus-Université, Lyon 1, France. Kidney International 2000 58, 51-61DOI: (10.1046/j.1523-1755.2000.00140.x) Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 4 Representative interstitial collagens deposition in untreated (on the left) and treated (on the right) rats, determined with Sirius red at week 12 (A and D, ×100) and with type III collagen monoclonal antibody (mAb) at week 2 (B and E) and at week 12 (C and F), respectively, after subtotal nephrectomy (×250). Reproduction of this figure in color was made possible by Ezus-Université, Lyon 1, France. Kidney International 2000 58, 51-61DOI: (10.1046/j.1523-1755.2000.00140.x) Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 5 Renal expression of glomerular (A), tubular (B), and interstitial (C) proliferating cell nuclear antigen (PCNA)-positive cells in treated (□) and untreated (▪) rats during the follow-up period. *P < 0.05; **P < 0.01; ***P < 0.005 vs. untreated rats. Kidney International 2000 58, 51-61DOI: (10.1046/j.1523-1755.2000.00140.x) Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 6 PCNA-positive cells in untreated (A) and treated (B) rats two weeks after subtotal nephrectomy (×250). Reproduction of this figure in color was made possible by Ezus-Université, Lyon 1, France. Kidney International 2000 58, 51-61DOI: (10.1046/j.1523-1755.2000.00140.x) Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 7 In vitro effect of mycophenolic acid (MPA) on rat fibroblast proliferation after 72 hours of incubation (in 10% FCS). Cell proliferation was studied using an MTT assay and the results are expressed as optical density (at λ = 750 nm). Results are mean ± SEM of four independent experiments. *P < 0.001; **P = 0.0001 vs. control. Kidney International 2000 58, 51-61DOI: (10.1046/j.1523-1755.2000.00140.x) Copyright © 2000 International Society of Nephrology Terms and Conditions